NordiQC - Immunohistochemical Quality Control

02

Oct

NordiQC Workshop in Diagnostic Immunohistochemistry 2024

Aalborg, Denmark - 2–4 Oct

04

Oct

NordiQC Workshop in Diagnostic Immunohistochemistry 2023

Aalborg, Denmark - 4–6 Oct

05

Oct

NordiQC Workshop in Diagnostic Immunohistochemistry 2022

Aalborg, Denmark - 5–7 Oct

1-1 SN Welcome

1-2 SN Pre-analytical phase

1-3/1-4 MB Analytical phase I & II

1-5 SN Tissue tool box for controls

1-6 DVH Validation and verification process for IHC

2-1 RR The unknown primary tumour

2-2 TJ Antibody selection, protocols and controls

2-3 SH Hematolymphoid neoplasms - IHC for diagnostic use

2-4 TJ Antibody selection, protocols and controls

2-5 AVL Breast cancer - IHC for diagnostic use

2-6 HLK Antibody selection, protocols and controls

2-8 HLK Antibody selection, protocols and controls

2-9 SN The antibody graveyard

3-1 ISK Immunocytochemistry - overview, considerations and applications

3-2 MB IHC double stains

3-3 SN IHC stainers - overview, pros and cons

3-5 MB In situ hybridization

Programme

29

Sep

NordiQC Workshop in Diagnostic Immunohistochemistry 2021

Aalborg, Denmark - 29 Sep–1 Oct

09

Oct

6th Academy of Diagnostic Immunohistochemistry

Krakow, Poland - 9–11 Oct

02

Oct

NordiQC Workshop in Diagnostic Immunohistochemistry

Aalborg, DK - 2–4 Oct

1-1 MV-Workshop introduction

1-2 ON-Pre-analytical 2019 I-II

1-3 MB-Analytical phase I-II

1-4 SN-Tissue toolbox for controls

2-1 MV-Unknown primary tumour

2-2 RR-Unknown primary tumour

2-3 HH-Lung cancer_IHC for diagnostic use

2-4 ON-Lung cancer, AB, protocols and controls

2-5 AVL-Breast cancer

2-6 RR-Breast cancer

2-7 SH-Haematololymphoid tumours

2-8 MB-Haematololymphoid tumours

3-1 MB-Immunohistochemical double stainings

3-2 ON-Frozen sections

3-3 SN-IHC stainers - overview, pros and cons

3-4 ON-Organizing IHC data

Programme

10

Oct

Academy of Immunohistochemistry

Krakow, Poland - 10–12 Oct

19

Sep

NordiQC Workshop in Diagnostic Immunohistochemistry

Aalborg, DK - 19–21 Sep

1-1 MV-Workshop introduction

1-2 MV-NordiQC EQA in IHC

1-3 ON-Pre-analytical 2018 I-II

1-4 MB-Analytic parameters 2018 I-II

1-5 RR-Controls

2-1 MV-Unknown primary tumours

2-2 MV-Unknown primary tumours

2-3 HH-Lung cancer, diagnosis and prediction

2-4 ON-Lung tumours

2-5 AVL-Breast cancer

2-6 RR-Breast cancer

2-7 SH-Haematololymphoid tumours

2-8 MB-Hematololymphoid tumours

3-1 MB-Immunohistochemical double stainings

3-2 ON-Frozen sections

3-3 ON-IHC stainer platforms

3-4 RR-Image analysis in IHC

Programme

13

Jun

QuIP/NordiQC Workshop in Applied Immunohistochemistry

Brugge, Belgium - 13–15 Jun

04

Jan

International Symposium on Immunohistochemistry

Tata Medical Center, Kolkata, India - 4–7 Jan

CT2_IHC_Lymphoma_India_2018

CT2_IHC_Precision_Med_India_2018

MV1_Impact_EQA_India_2018

MV2_IHC_Unknown_Primary_India_2018

MV3_IHC_GI_liver_pancr_India_2018

MV4_IHC_Lung_Pleura_India_2018

MV5_IHC_Endo_Kidn_Pros_Germ_India_2018

RB1_IHC_Breast_India_2018

RB2_IHC_Gyn_India_2018

SN1_Preanalyt_India_2018

SN2_Analyt_I_India_2018

SN3_Analyt_II_India_2018

SN4_QA_Unkown_Lymph_India_2018

SN5_QA_Breast_I_India_2018

SN6_QA_Breast_II_India_2018

SN7_QA_GYN_GI_India_2018

SN8_QA_Lung_India_2018

SN9_QA_ENDO_India_2018

06

Jun

3rd NordiQC Conference on Applied Immunohistochemistry

Aalborg, Denmark - 6–9 Jun